<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
task performance, fatigability, fatigue, clinical assessment, multiple sclerosis, Neuroscience, rehabilitation
task performance, fatigability, fatigue, clinical assessment, multiple sclerosis, Neuroscience, rehabilitation
1 Amato MP Portaccio E. Management options in multiple sclerosis-associated fatigue. Expert Opin Pharmacother (2012) 13:207–16.10.1517/14656566.2012.647767 22220738 [OpenAIRE] [PubMed] [DOI]
2 Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler (2003) 9:219–27.10.1191/1352458503ms904oa 12814166 [OpenAIRE] [PubMed] [DOI]
3 Minden SL Frankel D Hadden L Perloffp J Srinath KP Hoaglin DC. The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics. Mult Scler (2006) 12:24–38.10.1191/135248506ms1262oa 16459717 [OpenAIRE] [PubMed] [DOI]
4 Ford H Trigwell P Johnson M. The nature of fatigue in multiple sclerosis. J Psychosom Res (1998) 45:33–8.10.1016/S0022-3999(98)00004-X 9720853 [OpenAIRE] [PubMed] [DOI]
5 Janardhan V Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci (2002) 205:51–8.10.1016/S0022-510X(02)00312-X 12409184 [OpenAIRE] [PubMed] [DOI]
6 Motl RW McAuley E. Symptom cluster as a predictor of physical activity in multiple sclerosis: preliminary evidence. J Pain Symptom Manage (2009) 38:270–80.10.1016/j.jpainsymman.2008.08.004 19329276 [OpenAIRE] [PubMed] [DOI]
7 Motl RW McAuley E Wynn D Suh Y Weikert M. Effects of change in fatigue and depression on physical activity over time in relapsing-remitting multiple sclerosis. Psychol Health Med (2011) 16:1–11.10.1080/13548506.2010.521569 21218359 [OpenAIRE] [PubMed] [DOI]
8 Putzki N Katsarava Z Vago S Diener HC Limmroth V. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. Eur Neurol (2008) 59:136–42.10.1159/000111876 18057900 [OpenAIRE] [PubMed] [DOI]
9 Téllez N Río J Tintoré M Nos C Galán I Montalban X. Does the modified fatigue impact scale offer a more comprehensive assessment of fatigue in MS? Mult Scler (2005) 11:198–202.10.1191/1352458505ms1148oa 15794395 [OpenAIRE] [PubMed] [DOI]
10 Kluger BM Krupp LB Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology (2013) 80:409–16.10.1212/WNL.0b013e31827f07be 23339207 [OpenAIRE] [PubMed] [DOI]
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |